115 related articles for article (PubMed ID: 16331272)
1. Methylation-induced silencing of ASC and the effect of expressed ASC on p53-mediated chemosensitivity in colorectal cancer.
Ohtsuka T; Liu XF; Koga Y; Kitajima Y; Nakafusa Y; Ha CW; Lee SW; Miyazaki K
Oncogene; 2006 Mar; 25(12):1807-11. PubMed ID: 16331272
[TBL] [Abstract][Full Text] [Related]
2. Dual role of TMS1/ASC in death receptor signaling.
Parsons MJ; Vertino PM
Oncogene; 2006 Nov; 25(52):6948-58. PubMed ID: 16715133
[TBL] [Abstract][Full Text] [Related]
3. Methylation of the ASC gene promoter is associated with aggressive prostate cancer.
Collard RL; Harya NS; Monzon FA; Maier CE; O'Keefe DS
Prostate; 2006 May; 66(7):687-95. PubMed ID: 16425203
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells.
Liu HF; Hsiao PW; Chao JI
Chem Biol Interact; 2008 Oct; 176(1):48-57. PubMed ID: 18760266
[TBL] [Abstract][Full Text] [Related]
5. The methylation status of the TMS1/ASC gene in cholangiocarcinoma and its clinical significance.
Liu XF; Zhu SG; Zhang H; Xu Z; Su HL; Li SJ; Zhou XT
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):449-53. PubMed ID: 16911948
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
7. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer.
Xi Y; Formentini A; Nakajima G; Kornmann M; Ju J
Oncol Rep; 2008 Jan; 19(1):257-62. PubMed ID: 18097604
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
[TBL] [Abstract][Full Text] [Related]
9. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
10. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
11. PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.
Watanabe Y; Toyota M; Kondo Y; Suzuki H; Imai T; Ohe-Toyota M; Maruyama R; Nojima M; Sasaki Y; Sekido Y; Hiratsuka H; Shinomura Y; Imai K; Itoh F; Tokino T
Clin Cancer Res; 2007 Aug; 13(16):4786-94. PubMed ID: 17699856
[TBL] [Abstract][Full Text] [Related]
12. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
[TBL] [Abstract][Full Text] [Related]
13. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway.
Yang X; Fraser M; Moll UM; Basak A; Tsang BK
Cancer Res; 2006 Mar; 66(6):3126-36. PubMed ID: 16540663
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of serum p53 antibody detection in a chemosensitivity assay in cases of human colorectal cancer].
Takeda A; Shimada H; Nakajima K; Imaseki H; Okazumi S; Takayama W; Iwasaki K; Makino H; Natsume T; Kouno T; Kondo S; Suzuki T; Ochiai T; Isono K
Gan To Kagaku Ryoho; 2000 Jun; 27(6):879-83. PubMed ID: 10897215
[TBL] [Abstract][Full Text] [Related]
15. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
[TBL] [Abstract][Full Text] [Related]
16. Sodium butyrate restores ASC expression and induces apoptosis in LS174T cells.
Zhang S; Bai J; Ren S; Wang R; Zhang L; Zuo Y
Int J Mol Med; 2012 Dec; 30(6):1431-7. PubMed ID: 23064206
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of the CHFR gene is frequently detected in non-invasive colorectal cancer.
Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
Anticancer Res; 2006; 26(6B):4267-70. PubMed ID: 17201143
[TBL] [Abstract][Full Text] [Related]
18. Opposing securin and p53 protein expression in the oxaliplatin-induced cytotoxicity of human colorectal cancer cells.
Chiu SJ; Hsu TS; Chao JI
Toxicol Lett; 2006 Dec; 167(2):122-30. PubMed ID: 17045763
[TBL] [Abstract][Full Text] [Related]
19. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
20. Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin.
Ichikawa W; Ooyama A; Toda E; Sugimoto Y; Oka T; Takahashi T; Shimizu M; Sasaki Y; Hirayama R
Cancer Chemother Pharmacol; 2006 Dec; 58(6):794-801. PubMed ID: 16528528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
